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Abstract  
This study evaluated the chemopreventive effects of probiotic LaLp Dahi containing Lactobacillus acidophilus 
LaVK2 and Lactobacillus plantarumLp9 alone or as an adjunct with piroxicam (PXC)in male Wistar rats 
administered 1,2-dimethylehydrazine dihydrochloride (DMH). Colorectal carcinogenesis was induced by 
injecting DMH subcutaneously (40mg/kg body weight) twice a week for 2 weeks. Rats were divided into five 
groups, twenty four in each group and fed with the buffalo milk or probiotic supplements (20g) in addition to 
basal diet for 32 weeks.The rats were fed with buffalo milk or probiotic Dahi alone or in combination with PXC 
in addition to basal diet ad libitumand euthanized at 8th, 16th and 32nd weeks of the experiment and examined 
for development of aberrant crypt foci (ACF), mucin-depleted foci (MDF) and proliferating cell nuclear antigen 
(PCNA) labeling index. Administration of DMH in rats induced formation of preneoplastic lesions  (ACF and 
MDF) and increased PCNA index in colorectal tissue. Probiotic Dahi alone or in combination with piroxicam 
showed a significant (P<0.05) protective effects by loweringthe initiation and progression of DMH induced 
formation of preneoplastic lesions and PCNA labeling index. These observations suggest that probiotic LaLp 
Dahi alone or in combination with PXC may be used as a potential nutraceutical intervention in prophylaxis and 
treatment of colorectal cancer. 
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Introduction 
Colorectal cancer is the fourth most common 
cancer in men and the third most common 
cancer in women worldwide and is therefore a 
major health problem underlining the need for 
effective chemopreventive strategies [1]. 
Several studies have suggested that probiotics 
such as lactobacilli or bifidobacteria modulate 
the host resistance against intestinal infections 
and provide protective effects against colon 
cancer development [2, 3]. There exists a 
potential role for foods that contain probiotics 
to change the colonic microbiota in a way that 
might prevent diseases such as colorectal 
cancer. ACF are considered to be putative 
pre-neoplastic colon lesions since they are 
found in the colon of carcinogen-treated 
rodents [4, 5] and in patients at high risk for 
colon cancer development [6]. Biochemical, 
genetic and morphological studies have shown 
that ACF and colon tumors share similar 
alterations, further supporting the hypothesis 
that ACF are precursors of colorectal cancer. 
Mucin-depleted foci (MDF) have been 
identified as dysplastic lesions or crypts devoid 
of mucin that occur in the colon of carcinogen 
treated rats [6, 7] and also in humans at high 
risk of colon cancer [8]. MDF harbor mutations 
in genes affecting colon carcinogenesis and, 
like colonic tumours, show Wnt signaling 
activation, features suggesting that these 
lesions are precancerous [9, 10]. The 
expression of MUC2, the most abundant mucin 
in the colon, is dramatically reduced in MDF 
which leads to speculation that the focal loss of 
the protective mucous layer might activate local 
inflammation, which might drive 
carcinogenesis to more advanced stages [11]. 
MDF are dose-dependently induced by 
1,2-dimethylhydrazine dihydrochloride (DMH) 
and progressively increase in size after 
carcinogen administration. Recent 
investigations suggest that MDF can be also 
used as a promising biomarker for studying the 
effect of chemopreventive agents in colon 
carcinogenesis [8, 9,11]. Assessment of PCNA 
expression as an indicator of colonic crypt cell 
proliferation is another putative intermediate 
marker of colon cancer risk [12]. There are 
abundant reports on beneficial effects on 
probiotic Dahi on health and many 
investigators have suggested that the 
consumption of fermented dairy products, 
including probiotic Dahi, elicits anti-tumor 
effects [6, 7]. Dahi is fermented buffalo milk 
consumed in Indian sub-continent as a part of 
daily diet. It is prepared using mesophillic 
culture of lactococci, which are not probiotic in 
nature. However, Dahi can be a good medium 
for delivery of probiotic bacteria. We have 
prepared a buffalo milk based probiotic Dahi by 
co-culturing the selected strains of 
Lactobacillus acidophilus LaVK2 and 
Lactobacillus plantarumLp9 and Dahi starter. 
Recent studies from our laboratory have shown 
that this product attenuates the diet induced 
hypercholesterolemia in rats [13], and improves 
macrophage activity and confers protection 
against enteric infection in mice [13]. It 
reverses age related dysregulation of tissue 
antioxidant activities and decline in expression 
of biomarkers of ageing (peroxisome 
proliferators activated receptors–α, senescence 
marker protein-30 and klotho) in hepatic and 
kidney tissues [14], and alleviates age induced 
decline in macrophage and lymphocyte 
functions [15]. Being a fermented milk product, 
Dahi can be an excellent medium for delivery 
of probiotic strains that can provide protection 
against colorectal cancer. In this context, the 
present study was carried out for the first time 
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to evaluate the chemopreventive role of 
probiotic Dahi and its intervention with PXC on 
the development of preneoplastic lesions such 
as ACF, MDF and PCNA labeling index in male 
Wistarrats.The present study shows that this 
probiotic Dahi prevents the initiation and 
progression of pre-neoplastic lesions in DMH 
treated rats, and also improves the efficacy of 
treatment with piroxicam.  
Material and Methods 
Bacterial strains  
L. acidophilus LaVK2, Lactococcuslactisssp. 
cremoris NCDC-86 and L. lactisssp. 
lactisbiovardiacetylactis NCDC-60 were 
obtained from National Collection of Dairy 
Cultures, National Dairy Research Institute 
(NDRI), Karnal, India. Lactobacillus plantarum 
Lp9 was a generous gift from Dr. V. K. Batish, 
Emeritus Scientist, Dairy Microbiology 
Division, NDRI, Karnal. The lactobacilli and 
lactococci were propagated and maintained in 
MRS-broth and M17 broth (Himedia 
Laboratories Pvt. Ltd., Mumbai, India) at 37°C 
and 30°C, respectively, and were stored at 
4-8°C between transfers. L. plantarum and L. 
acidophilus were propagated and cultured at 
37°C for 24 h and 37°C for 48 h, respectively. 
Preparation of Dahi and probiotic Dahi 
(LaLp Dahi) 
Bacterial cultures were revitalized three times 
in reconstituted and autoclaved skim milk prior 
to use for preparation of fermented milk. 
Buffalo milk obtained from the cattle yard of 
the institute was standardized to 3.0% fat, 
heated to 90°C for 15 min and was then cooled 
to 37°C. Dahi was prepared by culturing 
standardized buffalo milk with Dahi starter 
culture (Lactococcus lactis ssp. cremoris and 
Lactococcus lactis ssp. Lactis 
biovardiacetylactis, 1% each) for 8 h at 30°C. 
Probiotic LaLp Dahi was prepared by 
inoculating buffalo milk with L. acidophilus 
LaVK2, L. plantarum Lp9 and Dahi starter 
(1.0%). The final product contained 2 x 
10
9
cfu/g of lactococci, L. plantarum and L. 
acidophilus each. 
Chemicals 
1,2-dimethylhydrazine dihydrochloride (DMH), 
piroxicam, alcian blue stain, Harris’ 
haematoxylin, monoclonal anti-PCNA antibody 
and 3,3-diaminobenzidine were purchased from 
Sigma-Aldrich Chemical Co. (St. Louis, MO, 
USA). The source of mouse ABC 
immunostaining system was Santa Cruz 
Biotechnology (Santa Cruz, California, U.S.A), 
N-N’-dimethyl-m-phenylenediamine and 
N-N’-dimethyl-pphenylenediamine were 
procured from National Chemicals Ltd., 
Bangalore, India All other chemicals were 
obtained from S D Fine-ChemLimited,Mumbai, 
India or Hi-Media Lab. Ltd., Mumbai, India. 
Animals and Diet 
Male Wistar rats (3 weeks of age) were 
obtained from Small Animal House of National 
Dairy Research Institute, Karnal, India. The 
animals were housed in stainless steel cages 
(three animals per cage) throughout the study, 
and room temperature was maintained at 25 ± 
2°C; 55 ± 5% humidity and at a 12-h light/12-h 
dark cycle.The animals were used and cared for 
in accordance with the principles and 
guidelines for human use and protocols were 
approved by the Institutional Ethics Committee. 
The composition of basal diet was starch, 63%; 
casein, 20%; soybean oil, 5.5%; cellulose, 5%; 
mineral mixture, 5%; vitamin mixture, 1%; D-L 
methionine, 0.2%; and choline chloride, 0.2%. 
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Mineral and vitamin mixture were prepared and 
mixed according to AOAC [16, 17]. 
Experimental design 
Animals were randomly divided into five 
groups, twenty four in each group and fed with 
the buffalo milk or probiotic supplements (20g) 
in addition to basal diet for 32 weeks. Rats of 
group I was fed with buffalo milk which served 
as control. Rats of group II (Milk-DMH) was 
administered DMH and served as the DMH 
control; rats of group III (Milk-DMH-PXC) 
was administered milk and PXC in DMH 
induced rats. Rats of group IV (LaLp 
Dahi-DMH) were accessible to probiotic Dahi 
and DMH, and rats of group V (LaLp 
Dahi-DMH-PXC) were offered both probiotic 
Dahi and PXC in DMH induced rats. Following 
28 d feeding, DMH (40 mg/kg body weight) 
was administered subcutaneously (s.c.) to the 
rats of the corresponding groups at twice a 
week for 2 weeks. PXC(4 mg/rat or 200 mg/kg 
of supplements) was given daily orally along 
with the supplements (milk/probiotic Dahi) and 
its feeding started one week after the last dose 
of DMH and continued till termination of 
experiment. Rats were sacrificed by cervical 
dislocation at 8th, 16th, 32th weeks of 
experimental time and colorectal tissues were 
examined for aberrant crypt foci (ACF), mucin 
depleted foci (MDF) and proliferating cell 
nuclear antigen (PCNA) labeling index.  
Identification of aberrant cryptfoci (ACF) 
Colorectal segments were removed, washed 
with saline,cut open longitudinally, fixed flat in 
10% buffered formalin and stained with 
methylene blue [18]. The ACF were 
characterised by their enlarged crypts elevated 
crypts from the surrounding epithelium, 
thickened epithelial layer, increased pericryptal 
space and their round or elongated luminal 
openings [19]. 
Identificationofmucindeficientfoci (MDF)  
After ACF determination, the colorectal 
segments were processed for high iron 
diaminealcian blue staining [15]. The MDF 
were characterized by having or very little 
mucin and fulfilled the criteria according to 
Caderniet al. [9]. The tissue were coded and 
scored independently by two observers. 
Immunostaining for proliferating cell 
nuclear antigen (PCNA) 
Following MDF determination, the colorectal 
tissues were embedded in paraffin such that the 
crypts could be sectioned longitudinally. The 
proliferative activity in the mucosa was 
evaluated by determining proliferating cell 
nuclear antigen (PCNA) immunoreactivity [20]. 
Sections were cut from paraffin-embedded 
tissue and mounted on poly-L-lysine coated 
slides were de-paraffinized and re-hydrated. 
The endogenous peroxidase activity was 
blocked with 1.0 % hydrogen peroxide in 
absolute methanol. The sections washed with 
phosphate-buffered saline (PBS) were stained 
with mouse ABC immunostaining system. 
Non-specific background staining was blocked 
with normal blocking serum, the slides were 
incubated for 60 min at 37
0
C with the primary 
antibody (mouse monoclonal anti-PCNA 
antibody) diluted 1:100 in PBS. After washing 
(thrice with PBS) the slides were incubated for 
30 min at 37
0
C with biotinylated goat 
anti-polyvalent secondary antibody. The slides 
were again washed (thrice with PBS) and then 
incubated for 30 min with avidin-biotinylated 
horseradish peroxidase reagent. Finally, the 
slides after rinsing thrice with PBS were treated 
for 5 min with 3, 3-diaminobenzidine. The 
slides were washed with deoinized water for 5 
min and counter stained with Harris’ 
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haematoxylin. Proliferative activity was 
evaluated by counting PCNA-positive nuclei in 
at least 10 full longitudinal crypt sections (from 
the base to the bottom of the crypt) under the 
light microscope [20]. The dark brown stained 
nuclei were considered PCNA positive. The 
PCNA positive index was calculated as the 
proportion of positive stained nuclei expressed 
in percentage. The microscopic slides were 
coded and read independently by two 
observers. 
Statistical analysis 
The results were expressed as the means ± SD 
for each group (n=8) and analyzed by One-way 
analysis of variance (ANOVA) followed by the 
Tukey post hoc test (SYSTAT version 6.0.1, 
SPSS Inc, Chicago, IL,USA). Differences were 
considered significant at P< 0.05. 
Results 
Effect on feed intake and body weight 
A significant decline in average feed intake as 
well as in body weight gain was observed in 
rats treated with DMH (Table 1). Treatment of 
DMH induced rats with either LaLp Dahi or 
PXC alone or LaLp Dahi adjuvant with PXC, 
restored feed intake to normal levels and 
increased the body weight significantly (P< 
0.05). 
 
Table 1  Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on feed intake and body weight of 
dimethylhydrazine (DMH) treated rats.  
 
 Groups Average feed intake 
(g/d/rat) 
Body weight (g) 
Initial Final Gain 
Buffalo milk 17.8
a
 ± 1.9 22.2
a
 ± 0.3 325.2
a
 ± 1.0 303.0
a
 ± 1.0 
Buffalo milk-DMH 11.4
b
 ± 2.0 22.8
a
 ± 0.4 237.0
b
 ± 3.5 214.3
b
 ± 3.6 
Buffalo milk-DMH-PXC 16.8
a
 ± 2.0 23.2
a
 ± 0.4 304.5
c
 ± 3.1 281.3
c 
± 3.2 
LaLp Dahi-DMH 16.2
a
 ± 1.9 23.1
a
 ± 0.3 324.9
a
 ± 1.4 301.8
a
 ±1.4 
LaLp Dahi-DMH-PXC 17.0
a
 ± 2.0 23.1
a
 ± 0.4 343.6
d
 ± 6.1 320.5
d
 ± 5.9 
Values are mean ± SD for n=8. DMH, 1,2-dimethylhydrazine dihydrochloride; PXC, piroxicam. 
a,b,c,d
Mean 
values within a column with unlike superscript letters were  significantly different (P<0∙05). 
 
Effect on aberrant crypts (AC) and aberrant crypt foci (ACF) formation 
Figure 1A shows the lateral view of aberrant 
crypt foci (ACF) in methylene blue stained 
colonic mucosa. The ACF protrudes towards 
the lumen and consists of several crypts that 
differ from surrounding crypts by their 
increased size, and thicker and deeply stained 
epithelial lining. Figure 1B depicts ACF 
consisting of 6 aberrant crypts. Figure 1C 
depicts ACF consisting of 4 aberrant crypts. 
Figure 1D and 1E depicts alcian blue-stained 
ACF having elliptical luminal opening. Figure 
1F shows the topographic view of ACF in high 
iron diamine-alcian blue (HID-AB) stained 
colonic mucosa, wherein the ACF consisting of 
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five aberrant crypts was stained blue while 
normal crypts purplish-black. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Topographic view and histological section of colonic mucosa. A, Lateral view of aberrant crypt foci 
(ACF) protruding towards the lumen, stained in methylene blue (magnification, 200x). B, ACF stained in 
methylene blue showing 6 aberrant crypts (AC) /ACF (magnification, 200x). C, ACF stained in methylene 
blue showing 5 aberrant crypts (AC) /ACF (magnification, 400x). D, ACF stained in alcian blue showing 6 
AC/ACF (magnification, 200x). E, ACF stained in alcian blue showing 8 AC/ACF (magnification, 200x). F, 
ACF stained in high iron diamine-alcian blue showing 5AC/ACF (magnification, 400x). G, Mucin depleted 
foci (MDF) stained in HID-AB (magnification, 200x). H, Mucin depleted foci (MDF) stained in HID-AB 
(magnification, 400x). I, Section of colonic mucosa treated with immunochemistry technique showing 
proliferating cell nuclear antigen (PCNA) expression (magnification, 400x). 
 
The development of aberrant crypt foci (ACF) 
at different time intervals in DMH injected rats 
has been shown in Figure 2 which clearly 
indicate the protective potential of probiotic 
LaLp Dahi alone or in combination with PXC 
against colorectal carcinogenesis. The ACF in 
DMH treated rats were present throughout the 
length of colorectal segment, with the incidence 
higher in mid and distal regions, and these 
regions accounted for approximately 90% of 
the total ACF.Further, the number of ACF 
increased with time in DMH treated rats.The 
DMH induced rats fed with LaLp Dahi or PXC 
or PXC and LaLp Dahi combined registered 
significantly lower numbers of AC and ACF 
than in Milk-DMH group. The total number of 
ACF at 8 week decreased by 49.5, 61.6 and 
72.0% in rats fed with piroxicam, LaLp Dahi, 
and LaLp Dahi and piroxicam combined, 
respectively, relative to Milk-DMH group. 
Although the total number of ACF at 16 week 
increased in each group, the proportion relative 
to Milk-DMH group remained almost same in 
rats fed piroxicam or LaLp Dahi or LaLp Dahi 
and piroxicam combined (i.e., 46.8, 53.5 and 
72.0%, respectively). While the total number of 
ACF continued to rise beyond 16 week in 
Milk-DMH group, it almost plateaued in rats 
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fed with piroxicam or LaLp Dahi or piroxicam 
and LaLp Dahi combined. When expressed as 
percent, total number of ACF at 32 weeks 
decreased by 59.2, 65.8, and 82.2% in rats fed 
piroxicam, LaLp Dahi, and LaLp Dahi and 
piroxicam combined, respectively, relative to 
Milk-DMH group. The LaLp Dahi was more 
efficacious than PXC in reducing the number of 
ACF in colorectum. A further reduction in 
number of ACF in colorectum was observed 
when animals were treated with probiotic Dahi 
and PXC combined. Figure 3 show that the 
feeding LaLp Dahi or piroxicam treatment 
significantly (P<0.05) reduced the multiplicity 
of aberrant crypts (AC) in ACF in colorectal 
segments. The proportion of ACF having more 
than three crypts at 16 weeks was 20.4, 24.7, 
and 23.1% in rats fed with piroxicam, LaLp 
Dahi, and LaLp Dahi and piroxicam combined, 
respectively, compared with 37.0% in 
Milk-DMH group. Furthermore, the proportion 
of ACF having more than 3 crypts at 32 weeks 
was 48.3% in Milk-DMH group, and it was 
reduced to 14.9, 21.0, and 12.0% in animals fed 
with piroxicam, LaLp Dahi, and LaLp Dahi and 
piroxicam combined, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on development of aberrant crypt 
foci (ACF) in colorectal tissue of dimethylhydrazine (DMH) treated rats. Values (mean± SD for n=8) with 
different superscript letters are significantly different (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on multiplicity of crypt per 
aberrant crypt foci (ACF) in colorectal tissue of dimethylhydrazine (DMH) treated rats. Values (mean± SD 
for n=8) with different superscript letters are significantly different (P<0.05). 
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Effect on mucin depleted foci (MDF) formation 
MDF are the preneoplastic lesions 
characterized by the absence or scant 
production of mucin, elevation of the lesion 
above the surface, nuclear stratification, crypt 
enlargement, nuclear crowding and severe 
dysplasia. Figure 1G and 1H shows the 
topographic view of mucin depleted foci 
(MDF) in HID-AB stained colonic mucosa. The 
administration of DMH in rats resulted in 
development of MDF in colorectum, which 
decreased in number after 16 weeks (Figure 4). 
The number of DMH induced MDF decreased 
significantly by treatment with piroxicam or 
LaLp Dahi. The number of large MDF 
(containing more than 4 AC) in Milk-DMH 
group increased with time throughout the 
experimental period (Figure 5). The treatment 
with piroxicam or probiotic Dahi significantly 
decreased the number of total as well as large 
MDF in colorectal segment. Unlike, in 
Milk-DMH group, there was no increase in 
number of large MDF beyond 16 weeks in 
groups treated with piroxicam or probiotic Dahi 
or probiotic Dahi and piroxicam combined. The 
probiotic Dahi was more effective than 
piroxicam in reducing the progression in 
number as well as in size of MDF. Further, in 
animals treated with combination of piroxicam 
and probiotic Dahi the number as well as the 
size of MDF in colorectal segment were 
significantly lower than in groups treated with 
piroxicam or probiotic Dahi alone, suggesting 
that probiotic Dahi improves the efficacy of 
cancer treatment with piroxicam.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on development of mucin depleted 
foci (MDF) in colorectal tissue of dimethylhydrazine (DMH) treated rats. Values (mean± SD for n=8) with 
different superscript letters are significantly different (P<0.05). 
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Figure 5 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on development of large 
(containing ≥ 4 aberrant crypts) mucin depleted foci (MDF) in colorectal tissue of dimethylhydrazine (DMH) 
treated rats. Values (mean± SD for n=8) with different superscript letters are significan tly different (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on proliferating cell nuclear 
antigen (PCNA) labeling index* in colorectal tissue of dimethylhydrazine (DMH) treated rats. Values 
(mean± SD for n=8) with different superscript letters are significantly different (P<0.05). *PCNA labeling 
index is the proportion of PCNA positive cells in a crypt.  
 
At 16 weeks, the number of MDF were 
reduced by 50.6, 71.9 and 88.0 % in rats treated 
with piroxicam, LaLp Dahi, and LaLp Dahi and 
piroxicam combined, respectively, and the 
corresponding diminutions in large MDF were 
42.1, 55.0 and 70.8%, respectively compared 
with Milk-DMH group. At 32 weeks, the total 
number of MDF decreased by 47.6, 65.8 and 
83.9% in rats fed piroxicam, LaLp Dahi, and 
LaLp Dahi and piroxicam combined, 
respectively, relative to Milk-DMH group 
(Figure 5). The corresponding decrease in large 
MDF was 48.7, 64.7, and 71.8%, respectively. 
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Effect on proliferating cell nuclear antigen 
(PCNA) labeling index 
Proliferating cell nuclear antigen (PCNA), a 
non-histone nuclear protein essential for DNA 
replication and repair, the content of which is 
increased during carcinogenesis, is used a 
prognostic marker in development of cancer. 
Figure 1I shows immunohistochemically 
stained longitudinal section of normal-looking 
crypt of buffalo milk fed rats showing 
expression of PCNA protein in cells of rat 
colonic epithelium.  The content of PCNA is 
increased during carcinogenesis, is used a 
prognostic marker in development of cancer. 
The data represented in Figure 6 shows that 
content of PCNA in cells is increased with the 
age even in normal animals, reaching at 32 
weeks 48% above 0 d level. In DMH-injected 
control rats the accumulation of PCNA at 32 
weeks increased 6-fold of that at 0 d level. The 
treatment with piroxicam or probiotic Dahi 
decreased DMH induced accumulation of 
PCNA in epithelial cells of colorectal tissue. 
The reductions in DMH induced accumulation 
of PCNA in epithelial cells of colorectal tissue 
were more pronounced in animals treated with 
the combination of piroxicam and probiotic 
Dahi. 
Discussion 
Aberrant crypt foci appear predominantly in the 
distal colon, are the precursors of colon cancer 
[6]. ACF growth is reported to occur through 
the mechanism of ‘‘crypt fission’’ [21] and 
therefore, the ACF with more number of crypts 
are characteristic of advanced cancer stage. 
Probiotic LaLp Dahi significantly (P<0.05) 
decreased the DMH induced progression of 
aberrant crypt foci. Piroxicam treatment also 
decreased the numbers of ACF; and the effect 
of PXC and probiotic Dahi was additive. The 
numbers of ACF having multiple aberrant 
crypts were very few in rats fed probiotic Dahi 
or treated with PXC or with combination of 
probiotic Dahi and PXC, while in DMH treated 
control these increased linearly with time. 
Mucin depleted foci are also promising 
biomarker for studying the effects of 
chemopreventive agents on colon 
carcinogenesis [7, 22, 23].The occurrence of 
MDF in high-risk patients provides evidence 
that these lesions have a counterpart in human 
pathology and, as observed in rodents, may 
represent the very early stages of colorectal 
cancer. In our study, feeding probiotic Dahi to 
DMH induced rats decreased significantly 
(P<0.05) the induction and progression of MDF. 
The treatment with PXC also decreased the 
induction and progression of DMH induced 
MDF, and the probiotic Dahi improved its 
efficacy. The reduction in number of MDF at 32 
weeks might be due to their transformation into 
tumors. The number of large MDF in DMH 
treated control group continued to rise 
throughout experimental period. The trend in 
appearance of neoplastic lesions in DMH 
treated control rats and the effect of piroxicam 
is similar to that reported earlier in the colon of 
F344 rats [7, 9]. The mechanism could possibly 
involve the interaction of mucin such as 
sialomucins or sulfomucinsin surface and upper 
crypt goblet cells with the metabolites of lactic 
acid culture in colorectal mucosa [32]. 
It is well known that PCNA is used as an 
indicator of DNA synthesis and cellular 
proliferation and has been used as an 
intermediate biomarker in chemoprevention of 
colorectal cancer [24]. Using 
immunohistochemistry, we identified that there 
was a large amount of positive expression of 
PCNA in the colorectum of DMH-injected 
control rats was increased six-fold of that at 0 d 
level. The PCNA labeling index increased 
significantly (P<0.05) in epithelial cells of rats 
injected with DMH, and the treatment with 
piroxicam or probiotic Dahi decreased this rise 
in PCNA index. The reductions in DMH 
induced accumulation of PCNA in epithelial 
cells of colorectal mucosa were more 
pronounced in animals treated with the 
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combination of piroxicam and probiotic Dahi. 
This indicates that the colorectal tissue were in 
an more active state of proliferation in 
DMH-injected control rats, which is a similar 
result to that reported in previous studies [25]. 
LaLp Dahi was equally or even more effective 
than piroxicam in reducing PCNA labeling 
index in colorectum of DMH treated rats. In 
addition, it is well established that increased 
PCNA- labeling index in colonic ACF, the 
known pre-neoplastic lesions, leads to higher 
risk for malignant progression [33]. It was 
concluded that suppression of cellular 
proliferation may represent one of the 
mechanisms through which probiotic Dahialone 
or as an adjunct with PXC exert their 
chemopreventive effects against DMH-induced 
colorectal cancer in the initiation phase and that 
probiotic Dahi had the potential to inhibit/slow 
colon tumorigenesis and to obstruct the growth 
and progression of hyperplastic foci into frank 
invasive tumors in the post-initiation phase in 
this rat model. These effects of probiotic Dahi 
are mediated, at least in part, through its ability 
to suppress cellular proliferation. Whether 
Probiotic Dahi induces apoptosis in our animal 
model of DMH-induced colorectal 
carcinogenesis and the possible mechanisms 
underlying this apoptotic efficacy are being 
investigated in our laboratory and the primary 
results are encouraging. 
The dietary treatment with probiotic Dahi 
was started four weeks before carcinogen 
administration showed protective effect was 
seen within two weeks. These results suggest 
that probiotics are active during initiation and 
early promotional phase of the carcinogenic 
process. The probiotic intervention may 
decrease exposure of the colonic epithelial cells 
to cytotoxic and genotoxic agents or may 
modulate the balance of colonic cell 
proliferation and apoptosis, and/or enhance the 
production of butyrate acetate, thereby 
improving mucosal structure [22, 23, 25]. The 
intestinal bacteria are capable of activating or 
deactivating proximal carcinogens, behaving as 
promoters and some as anti-promoters in colon 
carcinogenesis [25]. Several recent studies from 
our laboratory have shown that dietary 
LaBb-Dahi down regulates carcinogen 
activating cytochrome P450 enzymes CYP1A1, 
CYP1A2 and CYP1B1 in liver, and up regulates 
carcinogen detoxifying 
γ-glutamyltranspeptidase, 
UDP-glucuronosyltransferase and 
quinonereductase activities in liver as well as in 
colon [26].The potential of this product to 
improve macrophage and lymphocyte functions 
[14] and antioxidative status [15] has been also 
established.The effect of probiotic Dahi on 
biotransformation and/or disposition of DMH 
metabolites could influence the injury to the 
colonic mucosa and lower cell proliferation 
(PCNA labeling index) leading to reduced 
number of preneoplastic lesions. Recently, 
Mohania et al.[22] showed that this probiotic 
Dahi could also act as an antioxidant and can 
lower levels of TBARS, faecal β-glucuronidase 
and enhance the activity of 
glutathione-S-transferase (GST) in liver and 
colorectal tissues. However, future research 
may be needed to explore the molecular 
mechanism underlying the anticarcinogenic 
potential of probiotic Dahi alone or in 
combination of PXC to alleviate or reduce the 
colorectal carcinogenic effects of DMH.  
Conclusion 
In conclusion, the present study demonstrated 
that probiotic LaLp Dahi, administered alone or 
in combination with PXC has a 
chemopreventive effect against DMH-induced 
colorectal carcinogenesis in rat. This study also 
provided an evidence that probiotic Dahi 
appreciably suppressed the progression of 
preneoplastic lesions and cell proliferation in 
the post-initiation phase, which might make 
probiotic Dahi a promising agent to combat the 
progression of benign polyps and other 
pre-neoplastic lesions into malignant metastatic 
tumors and to manage colorectal cancer. These 
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findings suggest that probiotics Dahi could 
have a therapeutic potential to decrease the risk 
of colorectal cancer and be used as a potential 
nutraceutical intervention in prophylaxis and 
treatment of colorectal cancer. 
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